2020 annual financial data
Celldex Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -544.68%.
Operating income was -63,354,000 USD and net income was -59,780,000 USD.
Operating cash flow was -40,404,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,418,000 USD
- Operating income
- -63,354,000 USD
- Net income
- -59,780,000 USD
- Operating cash flow
- -40,404,000 USD